News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Peter Neumann

Articles by Peter Neumann

Correspondence regarding, "A Cost-Effectiveness Clinical Decision Analysis Model for Schizophrenia"

ByPenny Mohr,Peter Neumann,Karl Claxton,Ramy A Mahmoud,Dennis A. Revicki,Cynthia Palmer

August 1st 1998

Latest Updated Articles

Correspondence regarding, "A Cost-Effectiveness Clinical Decision Analysis Model for Schizophrenia"
Published: August 1st 1998 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

How Do GLP-1 Agonists Fit Into Stroke Care?

Exploring Identity, Appearance Experiences Among Patients With Alopecia

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text